- directed: true
  graph:
    disease: Hypertriglyceridemia
    disease_mesh: MESH:D015228
    drug: lovastatin
    drug_mesh: MESH:D008148
    drugbank: DB:DB00227
  links:
    - key: has metabolite
      source: MESH:D008148
      target: DB:DBMET01698
    - key: decreases activity of
      source: DB:DBMET01698
      target: UniProt:P04035
    - key: positively regulates
      source: UniProt:P04035
      target: GO:0016126
    - key: positively correlated with
      source: GO:0016126
      target: MESH:D014280
    - key: positively correlated with
      source: MESH:D014280
      target: MESH:D015228
  multigraph: true
  nodes:
    - id: MESH:D008148
      label: Drug
      name: lovastatin
    - id: DB:DBMET01698
      label: ChemicalSubstance
      name: 6'beta-Hydroxylovastatin
    - id: UniProt:P04035
      label: Protein
      name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    - id: GO:0016126
      label: BiologicalProcess
      name: sterol biosynthetic process
    - id: MESH:D014280
      label: ChemicalSubstance
      name: Triglycerides
    - id: MESH:D015228
      label: Disease
      name: Hypertriglyceridemia
  reference:
    - https://go.drugbank.com/drugs/DB00227#BE0000574
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL503/
    - https://en.wikipedia.org/wiki/Lovastatin#Mechanism_of_action
    - https://pubchem.ncbi.nlm.nih.gov/compound/53232#section=Metabolism-Metabolites
- directed: true
  graph:
    disease: Hyperlipidemia
    disease_mesh: MESH:D006949
    drug: lovastatin
    drug_mesh: MESH:D008148
    drugbank: DB:DB00227
  links:
    - key: has metabolite
      source: MESH:D008148
      target: DB:DBMET01698
    - key: decreases activity of
      source: DB:DBMET01698
      target: UniProt:P04035
    - key: positively regulates
      source: UniProt:P04035
      target: GO:0008610
    - key: increases abundance of
      source: GO:0008610
      target: CHEBI:18059
    - key: positively correlated with
      source: CHEBI:18059
      target: MESH:D006949
  multigraph: true
  nodes:
    - id: MESH:D008148
      label: Drug
      name: lovastatin
    - id: DB:DBMET01698
      label: ChemicalSubstance
      name: 6'beta-Hydroxylovastatin
    - id: UniProt:P04035
      label: Protein
      name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    - id: GO:0008610
      label: BiologicalProcess
      name: lipid biosynthetic process
    - id: CHEBI:18059
      label: ChemicalSubstance
      name: lipid
    - id: MESH:D006949
      label: Disease
      name: Hyperlipidemia
  reference:
    - https://go.drugbank.com/drugs/DB00227#BE0000574
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL503/
    - https://en.wikipedia.org/wiki/Lovastatin#Mechanism_of_action
    - https://pubchem.ncbi.nlm.nih.gov/compound/53232#section=Metabolism-Metabolites
- directed: true
  graph:
    disease: Hypercholesterolemia
    disease_mesh: MESH:D006937
    drug: lovastatin
    drug_mesh: MESH:D008148
    drugbank: DB:DB00227
  links:
    - key: has metabolite
      source: MESH:D008148
      target: DB:DBMET01698
    - key: decreases activity of
      source: DB:DBMET01698
      target: UniProt:P04035
    - key: positively regulates
      source: UniProt:P04035
      target: GO:0006695
    - key: positively correlated with
      source: GO:0006695
      target: CHEBI:16113
    - key: positively correlated with
      source: CHEBI:16113
      target: MESH:D006937
  multigraph: true
  nodes:
    - id: MESH:D008148
      label: Drug
      name: lovastatin
    - id: DB:DBMET01698
      label: ChemicalSubstance
      name: 6'beta-Hydroxylovastatin
    - id: UniProt:P04035
      label: Protein
      name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    - id: GO:0006695
      label: BiologicalProcess
      name: cholesterol biosynthetic process
    - id: CHEBI:16113
      label: ChemicalSubstance
      name: cholesterol
    - id: MESH:D006937
      label: Disease
      name: Hypercholesterolemia
  reference:
    - https://go.drugbank.com/drugs/DB00227#BE0000574
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL503/
    - https://en.wikipedia.org/wiki/Lovastatin#Mechanism_of_action
    - https://pubchem.ncbi.nlm.nih.gov/compound/53232#section=Metabolism-Metabolites
- directed: true
  graph:
    disease: Hypoalphalipoproteinemia
    disease_mesh: MESH:D052456
    drug: lovastatin
    drug_mesh: MESH:D008148
    drugbank: DB:DB00227
  links:
    - key: has metabolite
      source: MESH:D008148
      target: DB:DBMET01698
    - key: decreases activity of
      source: DB:DBMET01698
      target: UniProt:P04035
    - key: positively regulates
      source: UniProt:P04035
      target: GO:0008610
    - key: correlated with
      source: GO:0008610
      target: GO:0008654
    - key: increases abundance of
      source: GO:0008654
      target: MESH:D008075
    - key: positively correlated with
      source: MESH:D008075
      target: MESH:D052456
  multigraph: true
  nodes:
    - id: MESH:D008148
      label: Drug
      name: lovastatin
    - id: DB:DBMET01698
      label: ChemicalSubstance
      name: 6'beta-Hydroxylovastatin
    - id: UniProt:P04035
      label: Protein
      name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    - id: GO:0008610
      label: BiologicalProcess
      name: lipid biosynthetic process
    - id: GO:0008654
      label: BiologicalProcess
      name: phospholipid biosynthetic process
    - id: MESH:D008075
      label: ChemicalSubstance
      name: Lipoproteins, HDL
    - id: MESH:D052456
      label: Disease
      name: Hypoalphalipoproteinemia
  reference:
    - https://go.drugbank.com/drugs/DB00227#BE0000574
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL503/
    - https://en.wikipedia.org/wiki/Lovastatin#Mechanism_of_action
    - https://pubchem.ncbi.nlm.nih.gov/compound/53232#section=Metabolism-Metabolites
- directed: true
  graph:
    disease: Mixed hyperlipidemia
    disease_mesh: MESH:D006950
    drug: lovastatin
    drug_mesh: MESH:D008148
    drugbank: DB:DB00227
  links:
    - key: has metabolite
      source: MESH:D008148
      target: DB:DBMET01698
    - key: decreases activity of
      source: DB:DBMET01698
      target: UniProt:P04035
    - key: positively regulates
      source: UniProt:P04035
      target: GO:0008610
    - key: increases abundance of
      source: GO:0008610
      target: MESH:D008077
    - key: increases abundance of
      source: GO:0008610
      target: CHEBI:16113
    - key: increases abundance of
      source: GO:0008610
      target: CHEBI:17855
    - key: positively correlated with
      source: MESH:D008077
      target: MESH:D006950
    - key: positively correlated with
      source: CHEBI:17855
      target: MESH:D006950
    - key: positively correlated with
      source: CHEBI:16113
      target: MESH:D006950
  multigraph: true
  nodes:
    - id: MESH:D008148
      label: Drug
      name: lovastatin
    - id: DB:DBMET01698
      label: ChemicalSubstance
      name: 6'beta-Hydroxylovastatin
    - id: UniProt:P04035
      label: Protein
      name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    - id: GO:0008610
      label: BiologicalProcess
      name: lipid biosynthetic process
    - id: CHEBI:16113
      label: ChemicalSubstance
      name: cholesterol
    - id: MESH:D008077
      label: ChemicalSubstance
      name: Lipoproteins, LDL
    - id: CHEBI:17855
      label: ChemicalSubstance
      name: triglyceride
    - id: MESH:D006950
      label: Disease
      name: Mixed hyperlipidemia
  reference:
    - https://go.drugbank.com/drugs/DB00227#BE0000574
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL503/
    - https://en.wikipedia.org/wiki/Lovastatin#Mechanism_of_action
    - https://pubchem.ncbi.nlm.nih.gov/compound/53232#section=Metabolism-Metabolites
- directed: true
  graph:
    disease: Arteriosclerotic vascular disease
    disease_mesh: MESH:D001161
    drug: lovastatin
    drug_mesh: MESH:D008148
    drugbank: DB:DB00227
  links:
    - key: has metabolite
      source: MESH:D008148
      target: DB:DBMET01698
    - key: decreases activity of
      source: DB:DBMET01698
      target: UniProt:P04035
    - key: positively regulates
      source: UniProt:P04035
      target: GO:0006695
    - key: increases abundance of
      source: GO:0006695
      target: CHEBI:16113
    - key: positively correlated with
      source: CHEBI:16113
      target: HP:0002621
    - key: manifestation of
      source: HP:0002621
      target: MESH:D001161
  multigraph: true
  nodes:
    - id: MESH:D008148
      label: Drug
      name: lovastatin
    - id: DB:DBMET01698
      label: ChemicalSubstance
      name: 6'beta-Hydroxylovastatin
    - id: UniProt:P04035
      label: Protein
      name: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    - id: GO:0006695
      label: BiologicalProcess
      name: cholesterol biosynthetic process
    - id: CHEBI:16113
      label: ChemicalSubstance
      name: cholesterol
    - id: HP:0002621
      label: PhenotypicFeature
      name: atherosclerotic plaque formation
    - id: MESH:D001161
      label: Disease
      name: Arteriosclerotic vascular disease
  reference:
    - https://go.drugbank.com/drugs/DB00227#BE0000574
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL503/
    - https://en.wikipedia.org/wiki/Lovastatin#Mechanism_of_action
    - https://pubchem.ncbi.nlm.nih.gov/compound/53232#section=Metabolism-Metabolites
- directed: true
  graph:
    disease: Staphylococcal pneumonia
    disease_mesh: MESH:D011023
    drug: clavulanic acid
    drug_mesh: MESH:D019818
    drugbank: DB:DB00766
  links:
    - key: negatively regulates
      source: MESH:D019818
      target: InterPro:IPR012338
    - key: positively regulates
      source: InterPro:IPR012338
      target: GO:0008800
    - key: in taxon
      source: GO:0008800
      target: NCBITaxon:1280
    - key: causes
      source: NCBITaxon:1280
      target: MESH:D011023
  multigraph: true
  nodes:
    - id: MESH:D019818
      label: Drug
      name: clavulanic acid
    - id: InterPro:IPR012338
      label: GeneFamily
      name: Beta-lactamase/transpeptidase-like
    - id: GO:0008800
      label: MolecularActivity
      name: beta-lactamase activity
    - id: NCBITaxon:1280
      label: OrganismTaxon
      name: Staphylococcus aureus
    - id: MESH:D011023
      label: Disease
      name: Staphylococcal pneumonia
  reference:
    - https://go.drugbank.com/drugs/DB00766
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL777/
  comment: The drug is not effective by itself as an antibiotic and it can be combined with penicillin-group antibiotics.
- directed: true
  graph:
    disease: Pneumonia due to Klebsiella pneumoniae
    disease_mesh: MESH:D007710
    drug: clavulanic acid
    drug_mesh: MESH:D019818
    drugbank: DB:DB00766
  links:
    - key: negatively regulates
      source: MESH:D019818
      target: InterPro:IPR012338
    - key: positively regulates
      source: InterPro:IPR012338
      target: GO:0008800
    - key: in taxon
      source: GO:0008800
      target: NCBITaxon:573
    - key: causes
      source: NCBITaxon:573
      target: MESH:D007710
  multigraph: true
  nodes:
    - id: MESH:D019818
      label: Drug
      name: clavulanic acid
    - id: InterPro:IPR012338
      label: GeneFamily
      name: Beta-lactamase/transpeptidase-like
    - id: GO:0008800
      label: MolecularActivity
      name: beta-lactamase activity
    - id: NCBITaxon:573
      label: OrganismTaxon
      name: Klebsiella pneumoniae
    - id: MESH:D007710
      label: Disease
      name: Pneumonia due to Klebsiella pneumoniae
  reference:
    - https://go.drugbank.com/drugs/DB00766
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL777/
  comment: The drug is not effective by itself as an antibiotic and it can be combined with penicillin-group antibiotics.
- directed: true
  graph:
    disease: Rhinoscleroma
    disease_mesh: MESH:D012226
    drug: clavulanic acid
    drug_mesh: MESH:D019818
    drugbank: DB:DB00766
  links:
    - key: negatively regulates
      source: MESH:D019818
      target: InterPro:IPR012338
    - key: positively regulates
      source: InterPro:IPR012338
      target: GO:0008800
    - key: in taxon
      source: GO:0008800
      target: NCBITaxon:39831
    - key: causes
      source: NCBITaxon:39831
      target: MESH:D012226
  multigraph: true
  nodes:
    - id: MESH:D019818
      label: Drug
      name: clavulanic acid
    - id: InterPro:IPR012338
      label: GeneFamily
      name: Beta-lactamase/transpeptidase-like
    - id: GO:0008800
      label: MolecularActivity
      name: beta-lactamase activity
    - id: NCBITaxon:39831
      label: OrganismTaxon
      name: Klebsiella pneumoniae subsp. rhinoscleromatis
    - id: MESH:D012226
      label: Disease
      name: Rhinoscleroma
  reference:
    - https://go.drugbank.com/drugs/DB00766
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL777/
  comment: The drug is not effective by itself as an antibiotic and it can be combined with penicillin-group antibiotics.
- directed: true
  graph:
    disease: Pneumococcal pneumonia
    disease_mesh: MESH:D011018
    drug: clavulanic acid
    drug_mesh: MESH:D019818
    drugbank: DB:DB00766
  links:
    - key: negatively regulates
      source: MESH:D019818
      target: InterPro:IPR012338
    - key: positively regulates
      source: InterPro:IPR012338
      target: GO:0008800
    - key: in taxon
      source: GO:0008800
      target: NCBITaxon:1313
    - key: causes
      source: NCBITaxon:1313
      target: MESH:D011018
  multigraph: true
  nodes:
    - id: MESH:D019818
      label: Drug
      name: clavulanic acid
    - id: InterPro:IPR012338
      label: GeneFamily
      name: Beta-lactamase/transpeptidase-like
    - id: GO:0008800
      label: MolecularActivity
      name: beta-lactamase activity
    - id: NCBITaxon:1313
      label: OrganismTaxon
      name: Streptococcus pneumoniae
    - id: MESH:D011018
      label: Disease
      name: Pneumococcal pneumonia
  reference:
    - https://go.drugbank.com/drugs/DB00766
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL777/
  comment: The drug is not effective by itself as an antibiotic and it can be combined with penicillin-group antibiotics.
- directed: true
  graph:
    disease: Bacterial pneumonia
    disease_mesh: MESH:D018410
    drug: clavulanic acid
    drug_mesh: MESH:D019818
    drugbank: DB:DB00766
  links:
    - key: negatively regulates
      source: MESH:D019818
      target: InterPro:IPR012338
    - key: positively regulates
      source: InterPro:IPR012338
      target: GO:0008800
    - key: in taxon
      source: GO:0008800
      target: NCBITaxon:1313
    - key: causes
      source: NCBITaxon:1313
      target: MESH:D018410
  multigraph: true
  nodes:
    - id: MESH:D019818
      label: Drug
      name: clavulanic acid
    - id: InterPro:IPR012338
      label: GeneFamily
      name: Beta-lactamase/transpeptidase-like
    - id: GO:0008800
      label: MolecularActivity
      name: beta-lactamase activity
    - id: NCBITaxon:1313
      label: OrganismTaxon
      name: Streptococcus pneumoniae
    - id: MESH:D018410
      label: Disease
      name: Bacterial pneumonia
  reference:
    - https://go.drugbank.com/drugs/DB00766
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL777/
  comment: The drug is not effective by itself as an antibiotic and it can be combined with penicillin-group antibiotics.
- directed: true
  graph:
    disease: Infection due to Escherichia coli
    disease_mesh: MESH:D004927
    drug: clavulanic acid
    drug_mesh: MESH:D019818
    drugbank: DB:DB00766
  links:
    - key: negatively regulates
      source: MESH:D019818
      target: InterPro:IPR012338
    - key: positively regulates
      source: InterPro:IPR012338
      target: GO:0008800
    - key: in taxon
      source: GO:0008800
      target: NCBITaxon:562
    - key: causes
      source: NCBITaxon:562
      target: MESH:D004927
  multigraph: true
  nodes:
    - id: MESH:D019818
      label: Drug
      name: clavulanic acid
    - id: InterPro:IPR012338
      label: GeneFamily
      name: Beta-lactamase/transpeptidase-like
    - id: GO:0008800
      label: MolecularActivity
      name: beta-lactamase activity
    - id: NCBITaxon:562
      label: OrganismTaxon
      name: Escherichia coli
    - id: MESH:D004927
      label: Disease
      name: Infection due to Escherichia coli
  reference:
    - https://go.drugbank.com/drugs/DB00766
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL777/
  comment: The drug is not effective by itself as an antibiotic and it can be combined with penicillin-group antibiotics.
- directed: true
  graph:
    disease: Infection due to Staphylococcus aureus
    disease_mesh: MESH:D013203
    drug: clavulanic acid
    drug_mesh: MESH:D019818
    drugbank: DB:DB00766
  links:
    - key: negatively regulates
      source: MESH:D019818
      target: InterPro:IPR012338
    - key: positively regulates
      source: InterPro:IPR012338
      target: GO:0008800
    - key: in taxon
      source: GO:0008800
      target: NCBITaxon:1280
    - key: causes
      source: NCBITaxon:1280
      target: MESH:D013203
  multigraph: true
  nodes:
    - id: MESH:D019818
      label: Drug
      name: clavulanic acid
    - id: InterPro:IPR012338
      label: GeneFamily
      name: Beta-lactamase/transpeptidase-like
    - id: GO:0008800
      label: MolecularActivity
      name: beta-lactamase activity
    - id: NCBITaxon:1280
      label: OrganismTaxon
      name: Staphylococcus aureus
    - id: MESH:D013203
      label: Disease
      name: Infection due to Staphylococcus aureus
  reference:
    - https://go.drugbank.com/drugs/DB00766
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL777/
  comment: The drug is not effective by itself as an antibiotic and it can be combined with penicillin-group antibiotics.
- directed: true
  graph:
    disease: Urinary tract infectious disease
    disease_mesh: MESH:D014552
    drug: clavulanic acid
    drug_mesh: MESH:D019818
    drugbank: DB:DB00766
  links:
    - key: negatively regulates
      source: MESH:D019818
      target: InterPro:IPR012338
    - key: positively regulates
      source: InterPro:IPR012338
      target: GO:0008800
    - key: in taxon
      source: GO:0008800
      target: NCBITaxon:562
    - key: causes
      source: NCBITaxon:562
      target: MESH:D014552
  multigraph: true
  nodes:
    - id: MESH:D019818
      label: Drug
      name: clavulanic acid
    - id: InterPro:IPR012338
      label: GeneFamily
      name: Beta-lactamase/transpeptidase-like
    - id: GO:0008800
      label: MolecularActivity
      name: beta-lactamase activity
    - id: NCBITaxon:562
      label: OrganismTaxon
      name: Escherichia coli
    - id: MESH:D014552
      label: Disease
      name: Urinary tract infectious disease
  reference:
    - https://go.drugbank.com/drugs/DB00766
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL777/
  comment: The drug is not effective by itself as an antibiotic and it can be combined with penicillin-group antibiotics.
- directed: true
  graph:
    disease: Psoriasis
    disease_mesh: MESH:D011565
    drug: ustekinumab
    drug_mesh: MESH:D000069549
    drugbank: DB:DB05679
  links:
    - key: decreases activity of
      source: MESH:D000069549
      target: UniProt:P29460
    - key: positively regulates
      source: UniProt:P29460
      target: GO:0035722
    - key: positively regulates
      source: UniProt:P29460
      target: GO:0038155
    - key: positively regulates
      source: GO:0035722
      target: GO:0006954
    - key: positively regulates
      source: GO:0038155
      target: GO:0006954
    - key: positively correlated with
      source: GO:0006954
      target: MESH:D011565
  multigraph: true
  nodes:
    - id: MESH:D000069549
      label: Drug
      name: ustekinumab
    - id: UniProt:P29460
      label: Protein
      name: Interleukin-12 subunit beta
    - id: GO:0035722
      label: BiologicalProcess
      name: interleukin-12-mediated signaling pathway
    - id: GO:0038155
      label: BiologicalProcess
      name: interleukin-23-mediated signaling pathway
    - id: GO:0006954
      label: BiologicalProcess
      name: inflammatory response
    - id: MESH:D011565
      label: Disease
      name: Psoriasis
  reference:
    - https://go.drugbank.com/drugs/DB05679
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201835/
  comment: This drug binds to the p-40 subunit (UniProt:P29460) of both IL-12 (UniProt:P29459) and IL-23 (UniProt:Q9NPF7) so that they subsequently cannot bind to their receptors (https://en.wikipedia.org/wiki/Ustekinumab#Mechanism_of_action).
- directed: true
  graph:
    disease: Psoriasis with arthropathy
    disease_mesh: MESH:D015535
    drug: ustekinumab
    drug_mesh: MESH:D000069549
    drugbank: DB:DB05679
  links:
    - key: decreases activity of
      source: MESH:D000069549
      target: UniProt:P29460
    - key: positively regulates
      source: UniProt:P29460
      target: GO:0035722
    - key: positively regulates
      source: UniProt:P29460
      target: GO:0038155
    - key: positively regulates
      source: GO:0035722
      target: GO:0006954
    - key: positively regulates
      source: GO:0038155
      target: GO:0006954
    - key: positively correlated with
      source: GO:0006954
      target: MESH:D015535
  multigraph: true
  nodes:
    - id: MESH:D000069549
      label: Drug
      name: ustekinumab
    - id: UniProt:P29460
      label: Protein
      name: Interleukin-12 subunit beta
    - id: GO:0035722
      label: BiologicalProcess
      name: interleukin-12-mediated signaling pathway
    - id: GO:0038155
      label: BiologicalProcess
      name: interleukin-23-mediated signaling pathway
    - id: GO:0006954
      label: BiologicalProcess
      name: inflammatory response
    - id: MESH:D015535
      label: Disease
      name: Psoriasis with arthropathy
  reference:
    - https://go.drugbank.com/drugs/DB05679
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201835/
  comment: This drug binds to the p-40 subunit (UniProt:P29460) of both IL-12 (UniProt:P29459) and IL-23 (UniProt:Q9NPF7) so that they subsequently cannot bind to their receptors (https://en.wikipedia.org/wiki/Ustekinumab#Mechanism_of_action).
- directed: true
  graph:
    disease: Atherosclerosis
    disease_mesh: MESH:D050197
    drug: alirocumab
    drug_mesh: MESH:C571059
    drugbank: DB:DB09302
  links:
    - key: decreases activity of
      source: MESH:C571059
      target: UniProt:Q8NBP7
    - key: negatively regulates
      source: UniProt:Q8NBP7
      target: GO:0090118
    - key: negatively correlated with
      source: GO:0090118
      target: HP:0003141
    - key: positively correlated with
      source: HP:0003141
      target: HP:0031678
    - key: manifestation of
      source: HP:0031678
      target: MESH:D050197
  multigraph: true
  nodes:
    - id: MESH:C571059
      label: Drug
      name: alirocumab
    - id: UniProt:Q8NBP7
      label: Protein
      name: Proprotein convertase subtilisin/kexin type 9
    - id: GO:0090118
      label: BiologicalProcess
      name: receptor-mediated endocytosis involved in cholesterol transport
    - id: HP:0003141
      label: PhenotypicFeature
      name: Increased LDL cholesterol concentration
    - id: HP:0031678
      label: PhenotypicFeature
      name: Atherosclerotic lesion
    - id: MESH:D050197
      label: Disease
      name: Atherosclerosis
  reference:
    - https://go.drugbank.com/drugs/DB09302
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2109540/
    - https://en.wikipedia.org/wiki/Alirocumab#Pharmacology
- directed: true
  graph:
    disease: Hypercholesterolemia
    disease_mesh: MESH:D006937
    drug: alirocumab
    drug_mesh: MESH:C571059
    drugbank: DB:DB09302
  links:
    - key: decreases activity of
      source: MESH:C571059
      target: UniProt:Q8NBP7
    - key: negatively regulates
      source: UniProt:Q8NBP7
      target: GO:0090118
    - key: negatively correlated with
      source: GO:0090118
      target: HP:0003141
    - key: manifestation of
      source: HP:0003141
      target: MESH:D006937
  multigraph: true
  nodes:
    - id: MESH:C571059
      label: Drug
      name: alirocumab
    - id: UniProt:Q8NBP7
      label: Protein
      name: Proprotein convertase subtilisin/kexin type 9
    - id: GO:0090118
      label: BiologicalProcess
      name: receptor-mediated endocytosis involved in cholesterol transport
    - id: HP:0003141
      label: PhenotypicFeature
      name: Increased LDL cholesterol concentration
    - id: MESH:D006937
      label: Disease
      name: Hypercholesterolemia
  reference:
    - https://go.drugbank.com/drugs/DB09302
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2109540/
    - https://en.wikipedia.org/wiki/Alirocumab#Pharmacology
- directed: true
  graph:
    disease: Osteoarthritis
    disease_mesh: MESH:D010003
    drug: piroxicam
    drug_mesh: MESH:D010894
    drugbank: DB:DB00554
  links:
    - key: decreases activity of
      source: MESH:D010894
      target: UniProt:P23219
    - key: decreases activity of
      source: MESH:D010894
      target: UniProt:P35354
    - key: participates in
      source: UniProt:P23219
      target: REACT:R-HSA-2162123
    - key: participates in
      source: UniProt:P35354
      target: REACT:R-HSA-2162123
    - key: increases abundance of
      source: REACT:R-HSA-2162123
      target: MESH:D011453
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0002829
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0001386
    - key: positively correlated with
      source: HP:0001386
      target: MESH:D010003
    - key: positively correlated with
      source: HP:0002829
      target: MESH:D010003
  multigraph: true
  nodes:
    - id: MESH:D010894
      label: Drug
      name: piroxicam
    - id: UniProt:P23219
      label: Protein
      name: Prostaglandin G/H synthase 1
    - id: UniProt:P35354
      label: Protein
      name: Prostaglandin G/H synthase 2
    - id: REACT:R-HSA-2162123
      label: BiologicalProcess
      name: Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
    - id: MESH:D011453
      label: ChemicalSubstance
      name: Prostaglandins
    - id: HP:0002829
      label: PhenotypicFeature
      name: Arthralgia
    - id: HP:0001386
      label: PhenotypicFeature
      name: Joint swelling
    - id: MESH:D010003
      label: Disease
      name: Osteoarthritis
  reference:
    - https://go.drugbank.com/drugs/DB00554#mechanism-of-action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL527/
    - https://en.wikipedia.org/wiki/Piroxicam#Mechanism_of_action
- directed: true
  graph:
    disease: Rheumatoid arthritis
    disease_mesh: MESH:D001172
    drug: piroxicam
    drug_mesh: MESH:D010894
    drugbank: DB:DB00554
  links:
    - key: decreases activity of
      source: MESH:D010894
      target: UniProt:P23219
    - key: decreases activity of
      source: MESH:D010894
      target: UniProt:P35354
    - key: participates in
      source: UniProt:P23219
      target: REACT:R-HSA-2162123
    - key: participates in
      source: UniProt:P35354
      target: REACT:R-HSA-2162123
    - key: increases abundance of
      source: REACT:R-HSA-2162123
      target: MESH:D011453
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0002829
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0001386
    - key: positively correlated with
      source: HP:0001386
      target: MESH:D001172
    - key: positively correlated with
      source: HP:0002829
      target: MESH:D001172
  multigraph: true
  nodes:
    - id: MESH:D010894
      label: Drug
      name: piroxicam
    - id: UniProt:P23219
      label: Protein
      name: Prostaglandin G/H synthase 1
    - id: UniProt:P35354
      label: Protein
      name: Prostaglandin G/H synthase 2
    - id: REACT:R-HSA-2162123
      label: BiologicalProcess
      name: Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
    - id: MESH:D011453
      label: ChemicalSubstance
      name: Prostaglandins
    - id: HP:0002829
      label: PhenotypicFeature
      name: Arthralgia
    - id: HP:0001386
      label: PhenotypicFeature
      name: Joint swelling
    - id: MESH:D001172
      label: Disease
      name: Rheumatoid arthritis
  reference:
    - https://go.drugbank.com/drugs/DB00554#mechanism-of-action
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL527/
    - https://en.wikipedia.org/wiki/Piroxicam#Mechanism_of_action
